ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2025

Fibroblast-like Synoviocytes from Juvenile Idiopathic Arthritis and Controls Influence Expression of Bone Morphogenetic Protein Antagonists in Chondrocytes

Megan Simonds1, Amanda R. Schlefman2, Suzanne M. McCahan3, Kathleen E. Sullivan4, Carlos D. Rosé5 and AnneMarie C. Brescia5, 1Nemours, Nemours Biomedical Research, Wilmington, DE, 2Pediatric Rheumatology, Nemours/Thomas Jefferson University, Wilmington, DE, 3Nemours Biomedical Research, Wilmington, DE, 4Immunology ARC 1216, The Children's Hospital of Philadelphia, Philadelphia, PA, 5Nemours/Thomas Jefferson University, Wilmington, DE

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: chondrocytes, juvenile arthritis and synovial cells, synovial fluid

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Session Title: Pediatric Rheumatology – Basic Science Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibroblast-like synoviocytes (FLS) may play a role in the pathogenesis of Juvenile idiopathic arthritis (JIA) and have chondrogenic potential. Bone morphogenetic proteins (BMP) are necessary for chondrogenesis. We have previously shown increased levels of BMP4 in JIA FLS.  Highly conserved antagonists of BMPs regulate signaling in both FLS and chondrocytes (Ch) by binding to BMP ligands but little is known about how these antagonists interact in JIA FLS. To examine regulation of BMP signaling in Ch and FLS, we studied gene expression levels of BMP antagonists gremlin (GREM), chordin (CHRD), noggin (NOG), and follistatin (FST), as well as the expression of these antagonists in Ch cultured in FLS conditioned media.

Methods: RNA was collected from three Ch, CFLS, and JFLS cell lines cultured in their respective media at 6, 12, and 24 hours. Concurrently, RNA was collected from three Ch cell lines cultured in conditioned media from CFLS or JFLS (Ch-CFLS and Ch-JFLS) at the same time points. Clariom S microarrays were performed on these samples and log ratios calculated using linear expression values for genes of interest.

Results: In examining the expression levels of BMP antagonists in untreated cells, FST and a follistatin-like antagonist (FSTL5), inhibitors of BMP2, BMP4, and BMP7, are downregulated in CFLS and JFLS respectively compared to Ch. When studying the influence of FLS conditioned media on Ch, FSTL3 was significantly upregulated in Ch-CFLS compared to untreated Ch and Ch-JFLS compared to Ch-CFLS. GREM, a potent inhibitor of BMP2 and BMP4 was significantly upregulated in Ch-CFLS and Ch-JFLS when compared to untreated Ch while CHRD, also an inhibitor of BMP2 and BMP4, was significantly downregulated in Ch-JFLS compared Ch-CFLS.

Conclusion: Our results suggest that untreated Ch favor FST and family members as possible BMP signaling regulators but when cultured in FLS conditioned media, GREM, but not FST or CHRD, is upregulated in both Ch-CFLS and Ch-JFLS. FLS can influence chondrocytes by causing a change in the antagonist the cells use to regulate BMP signaling. Specifically, JFLS can influence Ch to downregulate CHRD and FSTL5 expression compared to Ch-CFLS. Perhaps JFLS, who have higher levels of BMP4 than CFLS, favor a more potent inhibitor like GREM, which is expressed more during late-stage chondrogenesis as opposed to FST, which is favored during earlier chondrogenesis (1).

1. Merino, R., et al. “The BMP Antagonist Gremlin Regulates Outgrowth, Chondrogenesis and Programmed Cell Death in the Developing Limb.” Development, The Company of Biologists Ltd, 1 Dec. 1999, dev.biologists.org/content/126/23/5515.

 

 


Disclosure: M. Simonds, None; A. R. Schlefman, None; S. M. McCahan, None; K. E. Sullivan, None; C. D. Rosé, None; A. C. Brescia, None.

To cite this abstract in AMA style:

Simonds M, Schlefman AR, McCahan SM, Sullivan KE, Rosé CD, Brescia AC. Fibroblast-like Synoviocytes from Juvenile Idiopathic Arthritis and Controls Influence Expression of Bone Morphogenetic Protein Antagonists in Chondrocytes [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/fibroblast-like-synoviocytes-from-juvenile-idiopathic-arthritis-and-controls-influence-expression-of-bone-morphogenetic-protein-antagonists-in-chondrocytes/. Accessed January 27, 2023.
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fibroblast-like-synoviocytes-from-juvenile-idiopathic-arthritis-and-controls-influence-expression-of-bone-morphogenetic-protein-antagonists-in-chondrocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences